Filter
8137
Filtered Results: 8137
Text search:
drugs
act
Featured
Recommendations
685
New Publications
2013
Language
Document type
No document type
4676
Studies & Reports
1260
Guidelines
1073
Manuals
395
Strategic & Response Plan
259
Fact sheets
189
Training Material
147
Situation Updates
38
Infographics
36
Brochures
28
Resource Platforms
24
Online Courses
8
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
470
Global
291
Kenya
231
South Africa
188
Uganda
164
Ethiopia
161
Nigeria
156
Western and Central Europe
154
Nepal
142
Sierra Leone
142
Tanzania
124
Zambia
121
Latin America and the Carribbean
119
Liberia
119
Africa
115
Malawi
114
Ghana
104
Bangladesh
99
Rwanda
98
Myanmar / Burma
97
Ukraine
87
Namibia
80
Eastern Europe
75
Philippines
65
Zimbabwe
58
Congo, Democratic Republic of
57
Asia
55
Russia
54
Senegal
51
South–East Asia Region
51
Indonesia
51
Syria
47
Cambodia
46
Lesotho
43
Burkina Faso
42
Mozambique
41
Germany
37
South Sudan
36
Botswana
35
Colombia
33
Brazil
31
Eswatini/ Swaziland
29
Haiti
27
Venezuela
26
Cameroon
25
West and Central Africa
23
East and Southern Africa
23
Guinea
22
Middle East and North Africa
22
Tajikistan
20
Benin
19
Peru
19
Eastern Europe and Central Asia
19
Paraguay
19
Argentina
19
Yemen
18
Chile
16
Sudan
16
Afghanistan
15
Vietnam
15
Pakistan
15
Albania
14
USA
14
Central African Republic
13
Thailand
12
Bolivia
12
Moldova
12
Georgia
12
China
11
Laos
11
Lebanon
11
Mali
11
Somalia
11
Madagascar
11
Western Pacific Region
10
Armenia
9
North America
9
Sri Lanka
9
North Macedonia
8
Mexico
8
El Salvador
8
Ecuador
8
Niger
6
Jordan
6
United Kingdom
6
Palestine
6
Chad
6
Iraq
6
Turkey
5
Iran
5
Burundi
5
Côte d’Ivoire / Ivory Coast
5
Angola
5
Libya
5
Bhutan
5
Timor Leste/ East Timor
4
Gambia
4
Fiji
4
Kyrgyzstan
4
Uzbekistan
4
Guinea-Bissau
4
Saudi Arabia
4
Jamaica
4
Spain
4
Southern Africa
4
Papua New Guinea
4
Egypt
4
Romania
4
Poland
4
Serbia
3
Kazakhstan
3
Morocco
3
Uruguay
3
France
3
Belarus
3
Djibouti
3
Greece
3
Honduras
3
Switzerland
2
Canada
2
Singapore
2
Estonia
2
Mongolia
2
Qatar
2
Dominican Republic
2
Hungary
2
Lithuania
2
Gabon
2
Turkmenistan
2
Belgium
2
Mauritius
2
Tunisia
2
Portugal
2
Nicaragua
2
Guatemala
2
North Korea
1
Australia
1
Togo
1
Congo-Brazzaville
1
Bulgaria
1
Mauritania
1
Italy
1
Ireland
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
3132
Clinical Guidelines
666
Public Health
376
Women & Child Health
341
Key Resources
277
Capacity Building
146
Pharmacy & Technologies
89
Annual Report MEDBOX
2
Toolboxes
HIV
880
Mental Health
788
TB
681
COVID-19
450
AMR
343
NTDs
312
Pharmacy
241
Caregiver
188
NCDs
171
Ebola & Marburg
144
Malaria
142
Refugee
121
Conflict
121
Planetary Health
120
Disability
116
Rapid Response
105
Global Health Education
86
Health Financing Toolbox
81
Natural Hazards
56
2.0 Rapid Response
42
Zika
37
Cholera
34
Specific Hazards
29
Social Ethics
28
Polio
28
South Sudan
2
The Ministry of Health, through the Zimbabwe Essential Drugs Action Programme, has produced this module for use by primary health care workers in Zimbabwe. The module aims to provide the minimum necessary knowledge for a nurse at a primary care unit. This material may also be used for the training o...
The pamphlet "Prescription Benzodiazepines" explains the uses, effects, and risks of benzodiazepines, commonly prescribed for insomnia, anxiety, and panic attacks. It describes how these drugs enhance GABA activity to suppress brain activity, leading to short-term effects like drowsiness and anxiety...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
GPHF-Minilab: Manuals
recommended
GPHF Minilab manuals on basic dye and thin layer chromatographic testing. The newest version of the manual (Volume I + II) from 2008 is available in three languages: English, French, Spanish. Combining the main manual with the supplements issued each year between 2010 and 2015, label claims on drug...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Antibiotics, also known as antimicrobial drugs, are medicines that can kill or inhibit the growth of bacteria to cure infections in people, animals and sometimes plants. Antibiotics are medicines for bacterial infections (such as pneumococcal pneumonia or staphylococcal bloodstream infections); anti...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Antibiotic Stewardship (AS) is a coordinated program that promotes the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of multi-drug resistant organisms. In clinical settings, stewardship activities focus on measuring and improving ...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Since the 1960s, the Tanzanian government has been striving to improve access to quality healthcare, including primary care. However, tuberculosis (TB) remains a significant public health concern, with an estimated prevalence rate of 528 cases per 100,000 people. However, currently, only 36% of TB c...
he tool will also provide visualization of the results after the SPPA is carried out. This protocol helps to plan surveys and mass drug administration activities that are more efficient and effective than what is done currently. The tool is being piloted in Kenya for schistosomiasis and designed suc...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
The publication conveys the quantitative surveillance results focusing on tobacco use and noncommunicable disease (NCD) related behaviours among youth (13–15 years) in Member States of the WHO South-East Asia Region, namely, the Global School-based Student Health Survey (GSHS) and the Global Youth...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
